Piramal Discovery Solutions offers a comprehensive range of Contract Research Services from our state-of-the-art research centre in India to support drug discovery activities.
Piramal has been offering from mg to gm scale discovery chemistries and have partnered with a range of well known pharmaceutical & biotechnology companies from North America, Europe and Asia.
Piramal's in-vitro labs provide ADME (absorption, distribution, metabolism, excretion) services for faster and improved decision making points for our Chemistry clients.
Non-GMP Kilo lab
Piramal’s fully-equipped kilo-lab allows for rapid development of scalable and robust chemical processes using advanced process methodologies to provide a quick supply in the early phase of the development.
Analytical Support Services
We have fully focussed"High Speed Delivery”process, a core element of which is our analytical support. The chemists at Piramal are supported by a specialist & fully dedicated analytical team which operates 24/7 with suites containing advanced analytical equipment.
An overview of Piramal’s Ahmedabad facility which offer drug discovery services to multinational pharmaceutical companies across the globe. The video highlights sites core competencies, such as discovery chemistry, analytical services and in vitro ADME Services.
An overview of Piramal's Ennore facility that offers Process Development Services, Analytical method development and Validation services, Stability studies etc. The video also showcase our site capabilities to develop and manufacture APIs and advanced intermediates.
Piramal offers contract manufacturing services for a wide variety of solid dose forms. Our global manufacturing sites located across North America, Europe and India offer the highest standards of quality and service to the customers.
We provide the manufacture and supply of Active Pharmaceutical Ingredients (APIs) on an integrated manufacturing model across North America, Europe and Asia.
Piramal Pharma Solutions now offers High Potency API (HPAPI) services following its acquisition of Ash Stevens, a leader in HPAPI development and cGMP.
With very small quantities of active pharmaceutical ingredients (API) or drug-able candidate molecules.
This video gives an overview of our Aurora facility in Toronto, providing insights on our drug development programmes and sites capabilities to handle products from early phase to late phase and all the way to commercial manufacturing.
Piramal’s Generic API division offers an indigenous basket of off-patent APIs for global markets. With the declining pipeline of new drugs in the pharmaceutical industry, our customers are looking for off-patent APIs with competitive cost and quality.
We have an experienced team of over 80 scientists (with over 20 Ph.D.’s) dedicated to innovation in new product development, cost optimization, and novel route scouting projects.